Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1971 1
1996 1
1997 1
2001 2
2002 2
2005 1
2006 1
2008 4
2009 8
2010 10
2011 6
2012 8
2013 9
2014 5
2015 5
2016 6
2017 2
2018 1
2019 2
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19407261

71 results
Results by year
Filters applied: . Clear all
Page 1
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.
Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, Wiebe N, Klarenbach S. Tonelli M, et al. CMAJ. 2009 May 26;180(11):E62-71. doi: 10.1503/cmaj.090470. Epub 2009 Apr 30. CMAJ. 2009. PMID: 19407261 Free PMC article. Review.
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.
Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, Bernhard J. Bohlius J, et al. Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Epub 2014 Apr 17. Br J Cancer. 2014. PMID: 24743705 Free PMC article. Review.
Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.
Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J. Vansteenkiste J, et al. Lung Cancer. 2012 Jun;76(3):478-85. doi: 10.1016/j.lungcan.2011.12.015. Epub 2012 Jan 25. Lung Cancer. 2012. PMID: 22277104 Free article.
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Bohlius J, et al. Lancet. 2009 May 2;373(9674):1532-42. doi: 10.1016/S0140-6736(09)60502-X. Lancet. 2009. PMID: 19410717
Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI. Hershman DL, et al. J Natl Cancer Inst. 2009 Dec 2;101(23):1633-41. doi: 10.1093/jnci/djp387. Epub 2009 Nov 10. J Natl Cancer Inst. 2009. PMID: 19903808 Free PMC article.
Erythropoiesis-stimulating agents in gynecological malignancies: A study-level meta-analysis.
Marchetti C, De Felice F, Palaia I, Musio D, Muzii L, Tombolini V, Benedetti Panici P. Marchetti C, et al. Crit Rev Oncol Hematol. 2016 Mar;99:123-8. doi: 10.1016/j.critrevonc.2015.12.013. Epub 2015 Dec 29. Crit Rev Oncol Hematol. 2016. PMID: 26748593 Review.
[Treatment of chemotherapy-induced anemia].
Kadokura G, Katsumata N. Kadokura G, et al. Gan To Kagaku Ryoho. 2014 Apr;41(4):416-20. Gan To Kagaku Ryoho. 2014. PMID: 24743356 Japanese.
Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients.
Rohner E, Grabik M, Tonia T, Jüni P, Pétavy F, Pignatti F, Bohlius J. Rohner E, et al. PLoS One. 2017 Dec 11;12(12):e0189309. doi: 10.1371/journal.pone.0189309. eCollection 2017. PLoS One. 2017. PMID: 29228059 Free PMC article. Review.
Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?
Bormanis J, Quirt I, Chang J, Kouroukis CT, MacDonald D, Melosky B, Verma S, Couture F. Bormanis J, et al. Crit Rev Oncol Hematol. 2013 Aug;87(2):132-9. doi: 10.1016/j.critrevonc.2012.12.010. Epub 2013 Jan 26. Crit Rev Oncol Hematol. 2013. PMID: 23357249 Review.
71 results
Jump to page
Feedback